Herceptin

Rediff.com » News » Herceptin

News for Herceptin

News
Business

Olive oil fights breast cancer

Olive oil might be the reason for the low breast cancer rate in Mediterranean nations. Olive oil is high in oleic acid. 'In laboratory experiments using breast-cancer cells, a US team has shown......

India partly revokes Roche cancer drug patent

India has partly revoked patents granted to Roche Holding AG for its breast cancer drug Herceptin, a spokesman for the drugmaker confirmed on Sunday.Swiss newspaper Schweiz am Sonntag reported that......

Biocon contests Roche claims on cancer drug

Biocon has lashed out at Roche a day after the Swiss company secured an order from the Delhi High Court barring the Indian company from marketing its new drug, co-developed with Mylan, as a......

Roche's patent pain to be Biocon's gain

Indian firm to soon launch copycat of anti-breast-cancer drug For Swiss pharma major Roche, not pursuing an Indian patent for its anti-breast-cancer drug, Herceptin, might mean a loss of millions......

'Judgment will ensure no ever-greening of patents'

Though the legal battle over Glivec’s patentability may be over for now, Y K Sapru, the man spearheading the fight against Swiss multinational Novartis, isn’t resting. Sapru, founder......

BDR wrestles Big Pharma in patents match

A month ago, Dharmesh Shah had enough time to spare for day-to-day activities of a lesser-known company -- BDR Pharma -- where he serves as chairman & managing director.However, in the last one......

Web results for Herceptin

Personalized Medicine and Companion Diagnostic Market - A Strategic Analysis of Industry Trends, Technologies, Participants, and Environment

This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic... ...

http://in.sys-con.com/node/2998314

PDL BioPharma Announces Fourth Quarter and Full Year 2013 Financial Results

INCLINE VILLAGE, Nev. , March3, 2014 /PRNewswire/ --PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today reported financial results for the fourth... ...

http://in.advfn.com/p.php?pid=nmona&article=61299150

New targeted therapies transform treatment - KOL Insight

/PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: ... ...

http://in.advfn.com/p.php?pid=nmona&article=61298939

TapImmune Releases Positive Interim Data on Phase I Clinical Trial in HER2/neu+ Breast Cancer

TapImmune Inc. (OTCQB:TPIVD) is pleased to report that analysis of the interim data from the first set of patients in a Phase I clinical trial show... ...

http://in.sys-con.com/node/2993790

Dr. Reddy''s Laboratories, Actavis, Amgen, Biogen Idec and eBay

CHICAGO , Feb. 27, 2014 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research... ...

http://www.asianhhm.com/news/news_archives.asp?NewsID=63784&title=The-Zacks-Analyst-Blog-Highlights-Dr-Reddys-Laboratories-Actavis-Amgen-Biogen-Idec-and-eBay

See All

Rediff News

Herceptin

News for Herceptin

Olive oil fights breast cancer

India partly revokes Roche cancer drug patent

Biocon contests Roche claims on cancer drug

Roche's patent pain to be Biocon's gain

'Judgment will ensure no ever-greening of patents'

BDR wrestles Big Pharma in patents match

Related Tags

Top Coverage News

Why I love India - Independence Day Special 2013

Lakme fashion week winter festive 2013

The Programmer Who Came In From The Cold

India News - Latest World & Political News - Current News Headlines in India : uttarakhand-disaster-2013

India Abroad Person of the Year 2012 - Rediff.com